arrow
J

John M.L. Ebos

department of cancer genetics and genomics
H指数:26
被引数:5,488

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer

ASO可视化摘要:ESR1表达与免疫细胞浸润及对免疫检查点抑制剂的应答呈负相关,见于ER阳性HER2阴性乳腺癌。

2025-10-220
PRE
ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

ASO作者反思:ER+/HER2–乳腺癌中免疫检查点抑制剂反应的预测因子:ESR1的新作用?

2025-09-170
PRE
ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer

ESR1表达与免疫细胞浸润及对免疫检查点抑制剂的应答呈负相关,见于雌激素受体阳性/HER2阴性乳腺癌。

2025-09-160
PRE
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2017-02-2877
OAAI